Gastrointestinal Stromal Tumor (GIST) Market is segmented By Product (Marketed Drugs, Phase III Pipeline Drugs), By Drug Category (Tyrosine Kinase Inhibitors, Chemotherap ....
The major players operating in the gastrointestinal stromal tumor (GIST) market include Novartis AG, Pfizer Inc., Bayer AG, Roche Holding AG, Eli Lilly and Company, Daiichi Sankyo, Astellas Pharma, Blueprint Medicines Corporation, Merck & Co., and Amgen Inc.
Gastrointestinal Stromal Tumor (GIST) Market